Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]
News [4645]
Articles [192]
Editorials [8]
Conferences [136]
elearning [9]
PARP inhibitors for prostate cancer: What oncology PAs should know
Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA
PARP inhibitors for prostate cancer: What oncology PAs should know ( Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA )
18 Dec 2020
ESMO 2020: New developments in the treatment of lung cancer
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2020: New developments in the treatment of lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
17 Dec 2020
SABCS 2020: Conference roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2020: Conference roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
16 Dec 2020
ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma
Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr...
ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma ( Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith )
15 Dec 2020
Survival analysis of newly diagnosed transplant-eligible multiple myeloma...
Dr Francesca Gay - University of Torino, Torino, Italy
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial ( Dr Francesca Gay - University of Torino, Torino, Italy )
14 Dec 2020
Latest data for managing ALK NSCLC patients
Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea
Latest data for managing ALK NSCLC patients ( Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea )
11 Dec 2020
Pregnancy outcomes in breast cancer survivors; meta-analysis
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Pregnancy outcomes in breast cancer survivors; meta-analysis ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
10 Dec 2020
Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk...
Dr Lori Leslie - John Theurer Cancer Center, Hackensack, USA
Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk CLL ( Dr Lori Leslie - John Theurer Cancer Center, Hackensack, USA )
9 Dec 2020
OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Dec 2020
Five year update of ECHELON-1 for classical Hodgkin lymphoma
Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil
Five year update of ECHELON-1 for classical Hodgkin lymphoma ( Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil )
8 Dec 2020
Real world management of multiple myeloma patients
Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina
Real world management of multiple myeloma patients ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )
8 Dec 2020
Clinical implications of MRD detection in infants with KMT2A-rearranged ALL...
Dr Janine Stutterheim - Princess Máxima Center, Utrecht, Netherlands
Clinical implications of MRD detection in infants with KMT2A-rearranged ALL Treated on the Interfant-06 protocol ( Dr Janine Stutterheim - Princess Máxima Center, Utrecht, Netherlands )
7 Dec 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation